| Document |
Document Title |
|
WO/2022/213895A1 |
The present invention provides a novel cationic lipid having a structure as shown in general formula (1) and particularly relates to a nitrogen-branched cationic lipid, and also relates to a liposome containing the cationic lipid, and a ...
|
|
WO/2022/214026A1 |
Disclosed in the present invention are a pegylated lipid and a preparation method therefor, a liposome comprising the pegylated lipid, and a pharmaceutical composition comprising the liposome and a preparation and use thereof, relating t...
|
|
WO/2022/202888A1 |
The purpose of the present disclosure is to provide a method for producing organic fluorine compounds that enables the thorough removal of sulfur-containing substances, or to provide an organic fluorine compound-containing composition th...
|
|
WO/2022/196819A1 |
The present invention establishes a non-conventional, novel method for producing D-luciferin and a D-luciferin derivative by a multi-stage production process without using expensive 2-cyano-6-hydroxybenzothiazole. The above is achieved...
|
|
WO/2022/198139A1 |
The present disclosure relates to compounds of Formula (I): (I) or pharmaceutically acceptable salts thereof. The present disclosure also relates to uses of the compounds, e.g., in treating or preventing diseases, disorders, or condition...
|
|
WO/2022/192781A1 |
The present disclosure provides phenalkylamine compounds and their use in treating medical disorders, such as psychiatric diseases and disorders. Pharmaceutical compositions and methods of making various phenalkylamine compounds are prov...
|
|
WO/2022/190486A1 |
The present invention provides, as a novel compound that can be utilized for efficient synthesis or the like of a polypeptide comprising various amino acids, a silane-containing condensed cyclic dipeptide compound represented by formula ...
|
|
WO/2022/185018A1 |
The invention relates to a method for preparing 2-hydroxy-4-methylthiobutyronitrile (HMTBN) or the selenium equivalent thereof (HMSeBN) from cyanhydric acid and 3-methylthiopropanal (MTP) or the corresponding selenium aldehyde (MSeP), co...
|
|
WO/2022/179448A1 |
The present invention belongs to the technical field of organic compound synthesis, and relates to a method for synthesizing (trifluoromethylthio) silver(I). The method for synthesizing (trifluoromethylthio) silver(I) (CAS No.: 811-68-7)...
|
|
WO/2022/181621A1 |
A condensed heterocyclic compound–containing composition comprising: a compound represented by general formula (A); and at least one compound selected from the group consisting of specific condensed heterocyclic compounds, specific aro...
|
|
WO/2022/168650A1 |
Provided are a novel homocysteine derivative and a method for producing the same, a composition comprising the compound, and an anti-inflammatory agent comprising the compound and/or the composition. A compound represented by formula 1.
|
|
WO/2022/169363A1 |
The invention provides a method for the extraction of an organic acid (10) from a mixture (110), the method comprising: an extraction stage comprising providing the mixture (110) to a sorbent (150); an elution stage comprising passing an...
|
|
WO/2022/166737A1 |
The present invention belongs to the field of agricultural insecticides and acaricides. In particular, the present invention relates to a biphenyl compound containing sulfide (sulfoxide) substitution and use thereof. The structure is as ...
|
|
WO/2022/166837A1 |
Disclosed are an aryl sulfide, a synthesis method therefor, and an application thereof. The aryl sulfide is a compound of the structure represented by formula I or an agriculturally acceptable salt thereof. The aryl sulfide and the agric...
|
|
WO/2022/163950A1 |
The present invention relates to a quantum dot composition, a preparation method therefor, and a cured film, a color filter and a display device which comprise same. Specifically, a solventless quantum dot composition according to the pr...
|
|
WO/2022/155728A1 |
Provided herein is a compound having a structure of Formula (I): (Formula (I)) wherein: D is S, O or an ester; p is 1 to 6; L1 and/or L2 are independently linear or branched C1-C30 alkyl, optionally having one or more C=C double bonds of...
|
|
WO/2022/156005A1 |
The present invention relates to the field of fine chemical engineering, and in particular, to a method for preparing an α-acyloxy-thioether derivative. The technical key points are as follows: compound A, carboxylic acid B, a sodium sa...
|
|
WO/2022/152705A1 |
Compounds of Formula (I) wherein R1, R3, R11, R12, X, Y1, Y2, Y3, Y4 and formula (II) are as defined in the description. Medicaments.
|
|
WO/2022/149461A1 |
The nonlinear light absorption material according to one mode of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R15 each independently include at least one atom selected...
|
|
WO/2022/144292A1 |
The invention relates in particular to a process for the preparation of DL/LD-methionine diketopiperazine (I) characterized in that a DD/LL-methionylmethionine-containing aqueous solution or suspension, which has a pH of 3 to 7, measured...
|
|
WO/2022/136641A1 |
The present invention generally relates to the field of ionizable (also termed cationic) lipids, and in particular provides a novel type of such lipids as represented by formula (I). The present invention further provides methods for mak...
|
|
WO/2022/117951A1 |
The present invention relates to a method for synthesising functionalised mercaptan, comprising the reaction between a compound of formula R2-X-C*H(NR1R7)-(CH2)n-G (II) and H2S in the presence of at least one enzyme chosen from among the...
|
|
WO/2022/116596A1 |
The invention relates to a concrete micro-foaming agent. The concrete micro-foaming agent contains the following components in parts by weight: 100-150 parts of a sulfonating agent, 0-100 parts of an alkaline agent, 100-200 parts of a un...
|
|
WO/2022/104137A1 |
The disclosure provides recording materials including propane derivatized monomers and polymers for use in volume Bragg gratings, including, but not limited to, volume Bragg gratings for holography applications. Several structures are di...
|
|
WO/2022/104113A1 |
The disclosure provides recording materials including mono- or poly-phenyl-core derivatized monomers and polymers for use in volume Bragg gratings, including, but not limited to, volume Bragg gratings for holography applications. Several...
|
|
WO/2022/090566A1 |
The present invention relates to the use of specific eugenol derivatives as stabilizers of organic materials against oxidative, thermal and/or actinic degradation. The present invention also relates to stabilized organic material and to ...
|
|
WO/2022/092655A1 |
Disclosed is a method for preparing a thiomethylphenol derivative, the method comprising steps of: (a) performing a primary reaction of a phenol derivative represented by chemical formula 2, a mercaptan derivative represented by R4SH, an...
|
|
WO/2022/084633A1 |
The invention relates to a preparation of a compound of formula (I), [Chem 1] CH3XCH2CH2C(NH2)COOH (I) wherein X represents S or Se, by catalytic conversion of a compound of formula (II) [Chem 2] CH3XCH2CH2C(Y)CN (II) wherein X represent...
|
|
WO/2022/084632A1 |
The invention relates to a method for preparing 2-hydroxy-4-methylthiobutyric acid (HMTBA) or 2-hydroxy-4-methylselenobutanoic acid (HMSeBA) by catalytic conversion of 2-hydroxy-4-methylthiobutyronitrile or of 2-hydroxy-4-methylselenobut...
|
|
WO/2022/082859A1 |
Provided is a refining method for an amino acid or derivatives thereof, comprising: (1) preparing a saturated aqueous solution of an amino acid or derivatives thereof from a crude product of the amino acid or derivatives thereof at prese...
|
|
WO/2022/079637A1 |
Analogues of oleuropein and oleacein and pharmaceutically acceptable salts thereof and processes for the preparation of these compounds are disclosed. The invention further relates to use of oleuropein and oleacein analogues for the trea...
|
|
WO/2022/080409A1 |
The present disclosure pertains to: an ester compound that is a transesterification reactant between a polyol and a dicarboxylic acid ester having a disulfide bond and that has, in a molecule chain, a disulfide bond and has, at a termina...
|
|
WO/2022/078940A1 |
The present invention relates to D,L-methionine, comprising based on the total weight of the D,L- methionine from 15 to less than 50 wt.-% of the D,L-methionine with a particle size from more than 0 to less 150 micrometer, from 50 to les...
|
|
WO/2015/136292A9 |
The invention relates to a DDX3X inhibitorfor use in the treatment of pneumovirus infection in a mammal, wherein the DDX3X inhibitor may be a compound of Formula (I) wherein y, Z, R1, X, L, Ra and Rb are as defined herein. The invention ...
|
|
WO/2022/071363A1 |
Provided is a new production method for a fluorinated organic compound (1) which involves a step A in which, in a liquid composition containing an organic solvent, IF5 is used to fluorinate a hydrogen atom-containing organic compound (2)...
|
|
WO/2022/051804A1 |
Compounds of Formula (A) and methods for use as agricultural chemicals, including herbicides. Formula (A)
|
|
WO/2022/043435A1 |
The present invention relates to a compound which can be used in the treatment of infections caused by SARS coronaviruses, e.g. by blocking the active site of the proteases 3CLpro and PLpro. The compound can be used as inhibitor or label...
|
|
WO/2022/043322A1 |
The present invention relates to compounds of formula (la) and the use thereof as inhibitors of P. aeruginosa virulence factor LasB. Formula (la). These compounds are useful in the treatment of bacterial infections, especially caused by ...
|
|
WO/2022/041739A1 |
The present invention belongs to the technical field of quaternary ammonium salt compounds, and specifically relates to a degradable quaternary ammonium salt compound. The structural general formula of the quaternary ammonium salt compou...
|
|
WO/2022/038477A1 |
The object of the invention concerns a quaternary ammonium salt of formula (I) wherein the substituents R5, R6 are independently chosen between hydrogen H and a radical R0, wherein the radical R0 consists of the structure of formula (II)...
|
|
WO/2022/029400A1 |
The present invention relates to an ectoparasiticide veterinary composition comprising a nutraceutical sourced from Allium sativum comprising at least one compound of the formula (I): wherein n is at least 4 and in which R1 is selected f...
|
|
WO/2022/018352A1 |
The present invention relates to a method for synthesising functionalised mercaptans, essentially in the absence of oxygen, as well as a composition particularly for implementing said method. The functionalised mercaptans have the follow...
|
|
WO/2022/012483A1 |
The present invention relates to the field of agricultural acaricides, and in particular to a substituted phenyl sulfide compound and an application thereof. The substituted phenyl sulfide compound is as represented by general formula I....
|
|
WO/2022/014702A1 |
Provided are a metal-organic framework suitably used as a functional material, and a method for manufacturing same, the metal-organic framework containing a cluster (α) and a cluster (β) as constituent units respectively, wherein the c...
|
|
WO/2022/012036A1 |
The present invention relates to the technical field of fine chemical industry. Disclosed is a method for preparing asymmetric disulfide. The specific steps comprise: using 3-methylthio-N-phenylpropionamide and diphenyl disulfide as raw ...
|
|
WO/2022/011174A1 |
Novel compounds and compositions including the same and methods of manufacturing and using the same, particularly for inhibiting HDAC or HDAC activity, and more particularly for enhancing renal recovery following acute kidney injury (AKI...
|
|
WO/2022/008505A1 |
The present invention relates to a process for preparing 3-methylthiopropionaldehyde, comprising the steps of a) providing a liquid stream (1) comprising methyl mercaptan and/or the hemi thioacetal formed from 3-methylthiopropionaldehyde...
|
|
WO/2021/258154A1 |
The present invention relates to TLR2 agonist compounds and their compositions, and the use of such compounds and compositions in the prevention and/or treatment of respiratory infections, or diseases or conditions associated with viral ...
|
|
WO/2021/255737A1 |
The present disclosure pertains to amino cyclohexanone compounds, pharmaceutical compositions containing same and methods of treating depression, pain, inflammation, and other clinical indications.
|
|
WO/2021/255552A1 |
Provided are amino acid based polymerizable compounds and their applications in ophthalmic devices. The amino acid based polymerizable compounds are of formula I: wherein R, R1, and R2 are as described herein.
|
